Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Research » Trials

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Weight Loss Nasal Spray Begins Clinical Trials
Posted: Thursday, December 28, 2006
PYY nasal spray trial demonstrates it produces satiety and a 30% reduction in calorie intake.

Diabetes Vaccine Trial Offers New Hope
Posted: Thursday, December 14, 2006
Hopes for a vaccine to guard against juvenile diabetes have been boosted with the launch of a ground-breaking clinical trial in Melbourne.

Diabetes Vaccine Trial Offers New Hope
Posted: Thursday, December 14, 2006
Hopes for a vaccine to guard against juvenile diabetes have been boosted with the launch of a ground-breaking clinical trial in Melbourne.

Diabetes Drug Shows Promises as Fatty Liver Treatment
Posted: Thursday, December 07, 2006
Actos is a drug used by millions of diabetics to control their blood may be valuable in preventing a common overlooked liver problem as well.

Nasal Insulin Expands Trial for Postpranidal Hyperglycemia Indication
Posted: Thursday, December 07, 2006
Bentley Pharmaceuticals, Inc., announced that, following successful review of its Investigational New Drug (IND) application by the FDA, a phase II program is now in effect and under way evaluating Bentley's human recombinant Intranasal Insulin Spray for the treatment of postprandial hyperglycemia in diabetics.



Naturlose A New Treatment for Diabetes Begins Phase 3 Trials
Posted: Thursday, December 07, 2006
Naturlose has a beneficial effect on modulating postprandial blood glucose.

Sitagliptin Role As Monotherapy, Adjunct
Posted: Thursday, November 30, 2006
The newly licensed glucose-lowering agent sitagliptin phosphate (Januvia) appears safe and somewhat effective. It could become a replacement for sulfonylurea, due to its ability to control blood sugars without weight gain and hypoglycemia.

Nasal Insulin Spray Moving Forward with Phase 2 Trials
Posted: Thursday, November 30, 2006
Two earlier studies conducted in Ireland with normal subjects and Type I diabetic patients demonstrated rapid absorption from the nasal spray and the expected glucose response.

Risk of Diabetes Reduced by 58% With Active Counseling and Continues After Counseling Stops
Posted: Wednesday, November 22, 2006
The effects of lifestyle intervention on diabetes risk do not disappear after active counseling has stopped, even after three plus years.

Rimonabant (Accomplia) to Treat Obesity and Improve Glycemic Control Approved in Mexico
Posted: Wednesday, November 22, 2006
Accomplia is now approved in Europe and Mexico, US next?

Page 20 of 23
 |<   <<   <  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement